Q4 EPS Estimates for AstraZeneca Raised by Leerink Partnrs
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Investment analysts at Leerink Partnrs raised their Q4 2025 EPS estimates for AstraZeneca in a report released on Monday, April 21st. Leerink Partnrs analyst A. Berens now expects that the company will earn $1.12 per share for the quarter, up from their prior estimate of $1.11. The consensus […]
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Investment analysts at Leerink Partnrs raised their Q4 2025 EPS estimates for AstraZeneca in a report released on Monday, April 21st. Leerink Partnrs analyst A. Berens now expects that the company will earn $1.12 per share for the quarter, up from their prior estimate of $1.11. The consensus […]
